Stemline Therapeutics Inc (STML) Annual Balance Sheets

Annual · GAAP · USD millions
Access STML quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Stemline Therapeutics Inc adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2019)
(Dec 31 2018) (Dec 31 2017) (Dec 31 2016) (Dec 31 2015)
Assets
Cash & cash equivalent13.56
Short-term Investments, Total150.87
Cash & Short-term Investments163.00
Accounts receivable15.12
Inventories1.15
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.46
Total Current Assets185.16
Equipment/Property/Plant Net0.19
Long-term investments0.00
Other Assets, Noncurrent1.00
Total Assets186.98
Liabilities
Accounts Payable and Accrued Liabilities, Current LI21.95
Accrued Liabilities, Current AC0.00
Other Liabilities, Current1.18
Deferred Revenue, Current DE0.00
Total Current Liabilities23.13
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent0.23
Total Liabilities23.36
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock529.49
Retained Earnings / Accumulated Deficit-365.91
Other Equity0.03
Common Stockholder's Equity163.62
Total Stockholder's Equity163.62
Liabilities & Stockholder's Equity186.98
4 historic quarters locked

Sign in to unlock the full Stemline Therapeutics Inc balance sheet history.

About STML Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.